Renato Cozzi

Summary

Country: Italy

Publications

  1. ncbi request reprint Primary treatment of acromegaly with octreotide LAR: a long-term (up to nine years) prospective study of its efficacy in the control of disease activity and tumor shrinkage
    Renato Cozzi
    Division of Endocrinology, Ospedale Niguarda, Viale Ezio 5, I 20149 Milan, Italy
    J Clin Endocrinol Metab 91:1397-403. 2006
  2. doi request reprint Octreotide long-acting repeatable for acromegaly
    Renato Cozzi
    Division of Endocrinology, Ospedale Niguarda, Via Canonica 81, I 20154 Milan, Italy
    Expert Rev Clin Pharmacol 5:125-43. 2012
  3. ncbi request reprint Pregnancy in acromegaly: a one-center experience
    Renato Cozzi
    Division of Endocrinology, Ospedale Niguarda, Milan, Italy
    Eur J Endocrinol 155:279-84. 2006
  4. ncbi request reprint Treatment of acromegaly with SS analogues: should GH and IGF-I target levels be lowered to assert a tight control of the disease?
    R Cozzi
    Division of Endocrinology, Niguarda Hospital, Milan, Italy
    J Endocrinol Invest 27:1040-7. 2004
  5. ncbi request reprint Cabergoline addition to depot somatostatin analogues in resistant acromegalic patients: efficacy and lack of predictive value of prolactin status
    Renato Cozzi
    Division of Endocrinology, Ospedale Niguarda, Carlo Besta Institute, Milan, Italy
    Clin Endocrinol (Oxf) 61:209-15. 2004
  6. ncbi request reprint Four-year treatment with octreotide-long-acting repeatable in 110 acromegalic patients: predictive value of short-term results?
    Renato Cozzi
    Division of Endocrinology, Ospedale Niguarda, I 20162 Milan, Italy
    J Clin Endocrinol Metab 88:3090-8. 2003
  7. ncbi request reprint Estroprogestinic pill normalizes IGF-I levels in acromegalic women
    R Cozzi
    Division of Endocrinology, Niguarda Hospital, Milan, Italy
    J Endocrinol Invest 26:347-52. 2003
  8. ncbi request reprint Lanreotide 60 mg, a new long-acting formulation: effectiveness in the chronic treatment of acromegaly
    Roberto Attanasio
    Endocrinology Unit, Niguarda Hospital, I 20162 Milan, Italy
    J Clin Endocrinol Metab 88:5258-65. 2003
  9. ncbi request reprint Gamma-knife radiosurgery in acromegaly: a 4-year follow-up study
    Roberto Attanasio
    Division of Endocrinology, Ospedale Niguarda, Milan, Italy
    J Clin Endocrinol Metab 88:3105-12. 2003
  10. doi request reprint Efficacy and tolerability of gamma knife radiosurgery in acromegaly: a 10-year follow-up study
    Cristina L Ronchi
    Department of Medical Sciences, University of Milan, Milan Unit of Endocrinology and Diabetology, Fondazione Ospedale Maggiore IRCCS, Milan, Italy
    Clin Endocrinol (Oxf) 71:846-52. 2009

Detail Information

Publications18

  1. ncbi request reprint Primary treatment of acromegaly with octreotide LAR: a long-term (up to nine years) prospective study of its efficacy in the control of disease activity and tumor shrinkage
    Renato Cozzi
    Division of Endocrinology, Ospedale Niguarda, Viale Ezio 5, I 20149 Milan, Italy
    J Clin Endocrinol Metab 91:1397-403. 2006
    ..Neurosurgery is regarded as the first-line treatment of acromegaly. Because of its low cure rate in macro and invasive adenoma, the role of primary medical treatment is debated...
  2. doi request reprint Octreotide long-acting repeatable for acromegaly
    Renato Cozzi
    Division of Endocrinology, Ospedale Niguarda, Via Canonica 81, I 20154 Milan, Italy
    Expert Rev Clin Pharmacol 5:125-43. 2012
    ..Treatment is well tolerated in most patients and can be safely prolonged for many years if required...
  3. ncbi request reprint Pregnancy in acromegaly: a one-center experience
    Renato Cozzi
    Division of Endocrinology, Ospedale Niguarda, Milan, Italy
    Eur J Endocrinol 155:279-84. 2006
    ..The aim of the study was the retrospective evaluation of pregnancy in acromegalic women attending our center...
  4. ncbi request reprint Treatment of acromegaly with SS analogues: should GH and IGF-I target levels be lowered to assert a tight control of the disease?
    R Cozzi
    Division of Endocrinology, Niguarda Hospital, Milan, Italy
    J Endocrinol Invest 27:1040-7. 2004
    ..The concordance between "safe" GH and normalised IGF-I levels during SA was also assessed, according to gender and gonadal status...
  5. ncbi request reprint Cabergoline addition to depot somatostatin analogues in resistant acromegalic patients: efficacy and lack of predictive value of prolactin status
    Renato Cozzi
    Division of Endocrinology, Ospedale Niguarda, Carlo Besta Institute, Milan, Italy
    Clin Endocrinol (Oxf) 61:209-15. 2004
    ..Even though some data were reported about the addition of cabergoline, a long-acting dopamine agonist (DA), to SA in resistant patients, definite data are still lacking...
  6. ncbi request reprint Four-year treatment with octreotide-long-acting repeatable in 110 acromegalic patients: predictive value of short-term results?
    Renato Cozzi
    Division of Endocrinology, Ospedale Niguarda, I 20162 Milan, Italy
    J Clin Endocrinol Metab 88:3090-8. 2003
    ....
  7. ncbi request reprint Estroprogestinic pill normalizes IGF-I levels in acromegalic women
    R Cozzi
    Division of Endocrinology, Niguarda Hospital, Milan, Italy
    J Endocrinol Invest 26:347-52. 2003
    ..This pilot study shows a marked IGF-I lowering effect of pill in acromegalic women, and warrants a prospective randomized study in patients resistant or partially sensitive to other medical treatments...
  8. ncbi request reprint Lanreotide 60 mg, a new long-acting formulation: effectiveness in the chronic treatment of acromegaly
    Roberto Attanasio
    Endocrinology Unit, Niguarda Hospital, I 20162 Milan, Italy
    J Clin Endocrinol Metab 88:5258-65. 2003
    ....
  9. ncbi request reprint Gamma-knife radiosurgery in acromegaly: a 4-year follow-up study
    Roberto Attanasio
    Division of Endocrinology, Ospedale Niguarda, Milan, Italy
    J Clin Endocrinol Metab 88:3105-12. 2003
    ....
  10. doi request reprint Efficacy and tolerability of gamma knife radiosurgery in acromegaly: a 10-year follow-up study
    Cristina L Ronchi
    Department of Medical Sciences, University of Milan, Milan Unit of Endocrinology and Diabetology, Fondazione Ospedale Maggiore IRCCS, Milan, Italy
    Clin Endocrinol (Oxf) 71:846-52. 2009
    ..The long-term efficacy and safety of stereotactic radiosurgery by gamma knife (GK) still remain unknown. The aim of the study was to investigate the long-term efficacy and tolerability of GK in acromegalic patients...
  11. ncbi request reprint Raloxifene lowers IGF-I levels in acromegalic women
    Roberto Attanasio
    Division of Endocrinology, Ospedale Niguarda, Viale Ezio 5, I 20149 Milan, Italy
    Eur J Endocrinol 148:443-8. 2003
    ....
  12. ncbi request reprint Effects of lanreotide Autogel on growth hormone, insulinlike growth factor 1, and tumor size in acromegaly: a 1-year prospective multicenter study
    Roberto Attanasio
    Division of Endocrinology, Joined Hospitals of Bergamo, Italy Pituitary Unit, Galeazzi Institute IRCCS, Milan, Italy
    Endocr Pract 14:846-55. 2008
    ..To evaluate the safety and effectiveness of lanreotide Autogel on growth hormone and insulinlike growth factor 1 (IGF-1) concentrations and tumor size in patients with acromegaly...
  13. ncbi request reprint GH/IGF-I normalization and tumor shrinkage during long-term treatment of acromegaly by lanreotide
    R Attanasio
    Division of Endocrinology, Niguarda Hospital, Milan, Italy
    J Endocrinol Invest 24:209-16. 2001
    ....
  14. ncbi request reprint A comparison between octreotide-LAR and lanreotide-SR in the chronic treatment of acromegaly
    R Cozzi
    Division of Endocrinology, Niguarda Hospital, Milan, Italy
    Eur J Endocrinol 141:267-71. 1999
    ....
  15. ncbi request reprint Lanreotide 60 mg, a longer-acting somatostatin analog: tumor shrinkage and hormonal normalization in acromegaly
    R Cozzi
    Division of Endocrinology, Niguarda Hospital, Milan, Italy
    Pituitary 3:231-8. 2000
    ..Somatostatin analogues are nowadays the milestone in the medical treatment of acromegaly. We evaluated the effects of a new 60 mg longer-acting formulation of lanreotide (LAN60) on GH/IGF-I levels and tumor size...
  16. ncbi request reprint Failure of radiotherapy in acromegaly
    R Cozzi
    Division of Endocrinology, Niguarda Hospital, Neurological Institute Carlo Besta, Milan, Italy
    Eur J Endocrinol 145:717-26. 2001
    ..Recent data has raised skepticism regarding the long-term effectiveness of radiotherapy (RxT) in acromegaly and its role as an ancillary tool to neurosurgery (Tx)...
  17. ncbi request reprint Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly
    Annamaria Colao
    Department of Molecular and Clinical Endocrinology and Oncology, Federico II University of Naples, Via S Pansini 5, 80131 Naples, Italy
    J Clin Endocrinol Metab 91:85-92. 2006
    ..Surgery is a cornerstone in the treatment of acromegaly, but its efficacy in large, invasive tumors is scant...
  18. ncbi request reprint Colonoscopic screening and follow-up in patients with acromegaly: a multicenter study in Italy
    Massimo Terzolo
    Dipartimento de Scienze Cliniche e Biologische, Clinica Medica, Universita di Torino, Italy
    J Clin Endocrinol Metab 90:84-90. 2005
    ..Patients who are found to harbor a colonic neoplasia are at risk for recurrence...